Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 5/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | PPARG | P37231 | 4/20 | 0.40 |
| ▸ | CTSS | P25774 | 5/20 | 0.39 |
| ▸ | CTSK | P43235 | 8/20 | 0.38 |
| ▸ | CTSL | P07711 | 1/20 | 0.38 |
| ▸ | CTSB | P07858 | 1/20 | 0.38 |
| ▸ | SYK | P43405 | 1/20 | 0.37 |
| ▸ | ACE | P12821 | 1/20 | 0.36 |
| ▸ | PPARD | Q03181 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31028245 | 0.88 | ATM (0.43) | PPARAATMPPARGCTSSCTSK | |
| SCHEMBL30096643 | 0.88 | ATM (0.43) | PPARAATMPPARGCTSSCTSK | |
| SCHEMBL28523987 | 0.88 | ATM (0.43) | PPARAATMPPARGCTSSCTSK | |
| SCHEMBL7842461 | 0.88 | ATM (0.46) | PPARAATMPPARGCTSSCTSK | |
| SCHEMBL30133471 | 0.88 | ATM (0.46) | PPARAATMPPARGCTSSCTSK | |
| SCHEMBL5548155 | 0.88 | ATM (0.46) | PPARAATMPPARGCTSSCTSK | |
| SCHEMBL31362545 | 0.86 | ATM (0.42) | ATMCTSSCTSKCTSLCTSB | |
| SCHEMBL28523692 | 0.86 | ATM (0.45) | PPARAATMPPARGCTSSCTSK | |
| SCHEMBL30096601 | 0.86 | ATM (0.45) | PPARAATMPPARGCTSSCTSK | |
| SCHEMBL31362303 | 0.84 | ATM (0.42) | PPARAATMPPARGCTSSCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025034858-A1 | FUSED PYRIDINES FOR THE TREATMENT OF CANCER AND OTHER INDICATIONS | THERAS, INC. (US) | 2025-02-13 | — | — | WO | disclosed |